ELIGIBILITY OF PATIENTS FOR ICOSAPENT ETHYL ACID (EPA) IN AN ARGENTINE REAL-WORLD POPULATION WITH TYPE 2 DIABETES MELLITUS

被引：0
|
作者：
Cobo, Augusto Lavalle [1 ,2 ]
Destaville, Josefina [2 ]
Forte, Ezequiel [2 ]
Corral, Pablo [3 ]
机构：
[1] Sanatorio Otamendi, Cardiol, Buenos Aires, DF, Argentina
[2] SAC, Cardiometab Council, Buenos Aires, DF, Argentina
[3] FASTA Univ, Sch Med, Mar Del Plata, Argentina
来源：
ATHEROSCLEROSIS | 2024年 / 395卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P508
引用
收藏
页数：1
相关论文
共 50 条
  • [1] ELIGIBILITY OF ICOSAPENT ETHYL (EPA) IN A FRENCH POPULATION OF CORONARY OUTPATIENTS WITH TYPE 2 DIABETES
    Sabouret, P.
    Dib, J. C.
    Dievart, F.
    Sharareh, A.
    Gallo, A.
    Guedj-Meynier, D.
    Huberman, J. -P.
    Cohen, S.
    Hoffman, O.
    Ouazana, L.
    Assouline, S.
    Lequeux, B.
    Khanoyan, P.
    Biondi-Zoccai, G.
    Rosencher, J.
    Tokgozoglu, L.
    Banach, M.
    Lellouche, N.
    ATHEROSCLEROSIS, 2023, 379 : S91 - S91
  • [2] Eligibility for icosapent ethyl in a French population of coronary outpatients with type 2 diabetes
    Sabouret, Pierre Francois
    Dib, Jean-Claude
    Ecarnot, Fiona
    Banach, Maciej
    Lellouche, Nicolas
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (06) : 1901 - 1903
  • [3] Eligibility for Icosapent Ethyl in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: An Analysis of VERTIS CV
    Kim, Joseph M.
    Bhatt, Deepak L.
    Dagogo-Jack, Samuel
    Cherney, David
    Cosentino, Francesco
    McGuire, Darren K.
    Pratley, Richard E.
    Liu, Chih-Chin
    Cater, Nilo B.
    Frederich, Robert
    Mancuso, James P.
    Cannon, Christopher P.
    DIABETES, 2022, 71
  • [4] Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus
    Kelly, Michael S.
    Scopelliti, Emily M.
    Goodson, Kaylee E.
    Lo, Ching Mann Anne
    Nguyen, Huelena X.
    Simon, Barbara
    DIABETES OBESITY & METABOLISM, 2024, 26 (12): : 5661 - 5668
  • [5] Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus
    Kang, Shinae
    Ahn, Yu-Bae
    Oh, Tae Keun
    Lee, Won-Young
    Chun, Sung Wan
    Bae, Boram
    Dahaoui, Amine
    Jeong, Jin Sook
    Jung, Sungeun
    Jang, Hak Chul
    DIABETES & METABOLISM JOURNAL, 2024, 48 (05)
  • [6] Eligibility and Awareness Regarding Metabolic Surgery in Patients With Type 2 Diabetes Mellitus in the Real-World Clinical Setting; Estimate of Possible Diabetes Remission
    Koliaki, Chrysi
    Tzeravini, Evangelia
    Papachristoforou, Eleftheria
    Severi, Ioanna
    El Deik, Elina
    Karaolia, Melina
    Noutsou, Marina
    Thanopoulou, Anastasia
    Kountouri, Aikaterini
    Balampanis, Konstantinos
    Lambadiari, Vaia
    Tentolouris, Nicholas
    Kokkinos, Alexander
    FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [7] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Susan Robinson
    Kristina S. Boye
    Reema Mody
    Alena Antonie Strizek
    Manige Konig
    Raleigh E. Malik
    Tessa Kennedy-Martin
    Diabetes Therapy, 2020, 11 : 1437 - 1466
  • [8] Real-World Effectiveness of Dulaglutide in Patients with Type 2 Diabetes Mellitus: A Literature Review
    Robinson, Susan
    Boye, Kristina S.
    Mody, Reema
    Strizek, Alena Antonie
    Konig, Manige
    Malik, Raleigh E.
    Kennedy-Martin, Tessa
    DIABETES THERAPY, 2020, 11 (07) : 1437 - 1466
  • [9] Correction to "Real-world evaluation of the effects of tirzepatide in patients with type 2 diabetes mellitus"
    Kelly, M. S.
    Scopelliti, E. M.
    Goodson, K. E.
    Lo, C. M. A.
    Nguyen, H. X.
    Simon, B.
    DIABETES OBESITY & METABOLISM, 2024,
  • [10] Real-World Effectiveness of Sitagliptin as Add-On Therapy in Patients With Type 2 Diabetes Mellitus
    Chen, Tse-Ying
    Hsieh, Ching-Jung
    POSTGRADUATE MEDICINE, 2014, 126 (03) : 205 - 215
12345